Skip to main content

Table 6 Multivariate analysis of prognostic factors for overall survival

From: Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome

 

P value

HR (95% CI)

Age (years)

0.007

6.277 (2.417 to 16.300)

Sex (male/female)

<0.001

4.119 (1.466 to 11.578)

Hemoglobin (g/L)

0.731

0.997 (0.983 to 1.012)

WBC (×109/L)

0.738

1.014 (0.935 to 1.100)

Platelet (×109/L)

0.823

1.000 (0.995 to 1.004)

BM blast (%)

0.245

1.041 (0.973 to 1.114)

IPSS risk group

<0.001

7.374 (3.746 to 14.518)

ID4 methylation level

0.011

2.371 (1.221 to 4.602)

  1. BM, bone marrow; WBC, blood cell counts; IPSS, International Prognostic Scoring System; ID4, inhibitor of DNA binding 4, 95% CI, 95% confidence interval.